Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids. Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids. conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids. Clinical research trials and Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids. medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids.. Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids. Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids. clinical trial. Participants frequently get the best healthcare available for their Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids. condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids.

Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids.



Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids.

For Condition: Kidney Transplantation,Graft Rejection
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: The purpose of this study is to see if BMS-224818 treatment will be as efficacious as cyclosporine at preventing acute rejection, and a superior safety / tolerability profile (better kidney function, better blood pressure, less lipid problems, less diabetes mellitus, etc.)
Details:
Eligibility:
Study Type:
  Interventional, Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria - Kidney transplant recipient Exclusion criteria - HLA-identical living-related donor/recipient pairs - active viral or bacterial infection - multiple organ transplant recipients - certain underlying causes of kidney failure
Total Enrollment: 

Location and Contact Information:

Medical Univ. of South Carolina
Charleston,  South Carolina,  29425
United States
 

Univ. of Nebraska Medical Center
Omaha,  Nebraska,  68198-1002
United States
 

Univ. of Pennsylvania
Philadelphia,  Pennsylvania,  19104
United States
 

Massachusetts General Hospital
Boston,  Massachusetts,  02114
United States
 

Mayo Clinic
Rochester,  Minnesota,  55905
United States
 

Univ. of Wisconsin
Madison,  Wisconsin,  53792-7375
United States
 

Emory Univ. School of Medicine
Atlanta,  Georgia,  30322
United States
 

Saint Barnabas Medical Center
Livingston,  New Jersey,  07039
United States
 

Univ. of Calif. - San Francisco
San Francisco,  California,  94143-0001
United States
 

Johns Hopkins University
Baltimore,  Maryland,  21205
United States
 

Baylor Univ. Medical Center
Dallas,  Texas,  75246
United States
 

Mount Sinai Medical Center
New York City,  New York,  10029-6574
United States
 


Additional Information:
Study ID Numbers:
  IM103-100; 
Study Start Date: 
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035555

Other Kidney Transplantation Studies:
1. Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys

2. Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants

3. Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids.

Related Studies:

Other Kidney Transplantation Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials

Study comparing the safety and efficacy of BMS-224818 to cyclosporine, in patients receiving a kidney transplant, when used in combination with CellCept, Simulect, and corticosteroids.

Modify your Search

  Other Kidney Transplantation Clinical Trials
  Other New York Clinical Trials
  Other New York City Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103